Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (5): 813-816    DOI: 10.31083/j.ejgo.2020.05.5330
Case Report Previous articles | Next articles
Recurrent immature teratoma in a 47 year old with maturation in subsequent laparotomies and a grave course
Sarita Kumari1, *(), Jai Bhagwan Sharma2
1Sarita Kumari, All India Institute of Medical Sciences, New Delhi, pin-110029, India
2Jai Bhagwan Sharma, Dept of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, pin-110029, India
Download:  PDF(590KB)  ( 145 ) Full text   ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Ovarian immature teratoma (IT) is uncommon after the first two decades of life. Management is largely surgical, and recurrences are rare. Ovarian IT has the potential to convert into mature disease at the time of recurrence. The current case report describes a 47-year-old female patient who developed two recurrences within three years. The primary disease and first recurrence were managed surgically, whereas the second recurrence was managed surgically plus adjuvant chemotherapy with bleomycin, etoposide and cisplatin (BEP) regimen. Histopathology was immature teratoma grade 3 initially which progressed to immature teratoma grade 1 in last recurrence. Alpha-feto protein levels were never raised except two months after the last laparotomy when the patient was diagnosed to have hepatic metastases and succumbed to disease. Prognosis was grave in our patient. Advanced age may be a one contributing factor. Relapse of ovarian IT is uncommon and its optimal management remains debatable.
Key words:  Recurrent immature teratoma      Ovarian      Surgery     
Submitted:  01 August 2019      Accepted:  14 January 2020      Published:  15 October 2020     
*Corresponding Author(s):  SARITA KUMARI     E-mail:  sarita2325@gmail.com

Cite this article: 

Sarita Kumari, Jai Bhagwan Sharma. Recurrent immature teratoma in a 47 year old with maturation in subsequent laparotomies and a grave course. European Journal of Gynaecological Oncology, 2020, 41(5): 813-816.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.05.5330     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I5/813

[1] Buse Güler, Merve Çamlıbel, Samiye Mete. What Do Relatives of Turkish Women with Ovarian Cancer Share on Websites? : A Qualitative Research[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 732-738.
[2] Jisu Yeom, Seulki Lee, Youngsun Kim. Hypercalcemia associated with primary mucinous ovarian tumor followed by pseudomyxoma peritonei can be fatal: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 824-827.
[3] Ji Geun Yoo, Hae Nam Lee, Sung Jong Lee, Jin Hwi Kim, Yong Seok Lee, Ahwon Lee, Soo Young Hur, Keun Ho Lee. Germline BRCA2 mutation is associated with greater progression-free survival in korean women with advanced high-grade serous ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 675-680.
[4] Yudi Mulyana Hidayat, Gatot Nyarumenteng Adhipurnawan Winarno, Maringan Diapari Lumban Tobing, Arieff Kustiandi, Kemala Isnainiasih Mantilidewi, Sofie Rifayani Krisnadi. The Role of Akt2 and CA-125 Serum Levels as Predictors for Successful Cytoreduction in Epithelial Ovarian Cancer Surgery[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 739-744.
[5] Qianqian Tang, Shi Wan, Xiaogai Qiao, Fang Wang, Yan Wang. MiR-29 promotes ovarian carcinoma cell proliferation through the PTEN pathway[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 774-778.
[6] Lingyun Zhai, Lixin Zeng, Hongru Jiang, Wei Li. Effects of a cyclooxygenase-1-selective inhibitor in combination with taxol or cisplatin on cyclin D1, apoptosis, and vascular endothelial growth factor in a xenograft model of ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 779-784.
[7] Špela Smrkolj, Snježana Frković Grazio, Renata Košir Pogačnik. Endocervical adenocarcinoma in situ with ovarian metastasis: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 802-805.
[8] Qihua Yi, Lin Chen, Sijing Chen, Ying Zheng. Criteria for predicting ovarian metastasis in early-stage cervical adenocarcinoma[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 726-731.
[9] Qinglian Ma, Wenjie Yan, Jing Yang, Haiyan Wang, Weixiang Wang, Minghui Dong. Functional interpretation of ovarian cancer in correlation with ISGF3 expression pattern[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 769-773.
[10] Adrius Gaurilcikas, Migle Gedgaudaite, Saulius Paskauskas, Tomas Birzietis, Daiva Vaitkiene. Unusual case of Krukenberg tumors diagnosed in early pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 806-809.
[11] Ana Carolinne da Silva, Isac Souza Silva Rodrigues, Antônio Carlos Oliveira de Meneses, Eddie Fernando Candido Murta, Rosekeila Simões Nomelini. Ectopic pregnancy concomitant with borderline ovarian tumor[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 810-812.
[12] Rie Nakamura, Yuko Shimoji, Tadaharu Nakasone, Yusuke Taira, Yoshihisa Arakaki, Tomoko Nakamoto, Keiko Mekaru, Wataru Kudaka, Tatsuya Kinjo, Yoichi Aoki. Malignant bowel obstruction in recurrent gynecologic cancers: who will benefit from palliative surgical intervention?[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 513-516.
[13] Silvia Ortega, José Angel Mínguez, José Manuel Aramendía, Marta Santisteban, Fernando Martinez-Regueira, Pablo Martí-Cruchaga, Juan Luis Alcázar, Matías Jurado. The impact of secondary cytoreductive surgery on survival in first recurrence of platinum sensitive epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 523-530.
[14] Jae Hong Sang, Soo-Ho Chung. Is it enough in ovarian cancer staging surgery to laparoscopic surgery? Comparison of surgical methods[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 541-544.
[15] Krittiya Somaketarin, Charuwan Tantipalakorn, Kittipat Charoenkwan, Prapaporn Suprasert, Jatupol Srisomboon. Survival outcomes of sex cord-stromal tumors of the ovary[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 563-568.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Akanksha Agrawal, Deepanshu Jain, Pradhum Ram, Jorge Luis Penalver Leon, Janani Rangaswami. Anticoagulation for intra-cardiac thrombi in peripartum cardiomyopathy: A review of the literature[J]. Reviews in Cardiovascular Medicine, 2019, 20(2): 53 -58 .
[3] B. Soltész, J. Lukács, A. Penyige, R. Póka, B. Nagy. Determination of miR-193b rs30236 single nucleotide polymorphism in ovarian cancer patients[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 547 -550 .
[4] Y. Li, C. Li, N. Li, L. Jiang, W. Yang, Y. Wang, B. Wu, C. Shi, Z. Zhu. RNAi silenced NUP88 gene suppresses growth and invasiveness of human breast cancer cell line MCF-7[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 634 -639 .
[5] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[6] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .
[7] Z. Protrka, P. Arsenijevic, N. Jovic, S. Zivanovic, J. Djuric, A. Dimitrijevic. A case of uterine torsion in term pregnancy associated with placental abruption and intrauterine fetal demise[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 287 -289 .
[8] T. Ueno, H. Yabushita, K. Iwasaki, A. Wakatsuki. Role of adiponectin and leptin in non-diabetic, non-obese patients with endometrial cancer[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 199 -204 .
[9] P. Pimsi, W. Santimaleeworagun, S. Therasakvichya, N. Saengsukkasemsak, A. Laocharoenkeat. The incidence and risk factors of severe neutropenia and febrile neutropenia due to chemotherapy among gynecologic cancer patients in Thailand[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 242 -246 .
[10] F. Lai-Tiong. Dermatomyositis revealing a 18-year breast cancer recurrence[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 292 -293 .